We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLRD
6001
CALL
DELISTED
Tailored Brands, Inc.
TLRD
$743K ﹤0.01%
128,700
-35,100
-21% -$243K
BAH icon
6002
PUT
Booz Allen Hamilton
BAH
$9.32B
$742K ﹤0.01%
11,200
+7,600
+211% +$467K
INGR icon
6003
PUT
Ingredion
INGR
$6.63B
$742K ﹤0.01%
9,000
+2,900
+48% +$249K
QGEN icon
6004
PUT
Qiagen
QGEN
$8.87B
$742K ﹤0.01%
17,258
+9,053
+110% +$375K
RETA
6005
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$742K ﹤0.01%
7,869
-6,828
-46% -$590K
HRTX icon
6006
PUT
Heron Therapeutics
HRTX
$63.9M
$740K ﹤0.01%
39,800
-14,100
-26% -$282K
MPT
6007
Medical Properties Trust
MPT
$2.5B
$740K ﹤0.01%
42,467
-898,882
-95% -$16.2M
MEDP icon
6008
CALL
Medpace
MEDP
$16.1B
$739K ﹤0.01%
11,300
-11,100
-50% -$640K
CHIX
6009
DELISTED
Global X MSCI China Financials ETF
CHIX
$739K ﹤0.01%
+44,954
New +$749K
CSR
6010
Centerspace
CSR
$938M
$738K ﹤0.01%
12,575
+6,136
+95% +$365K
CSWC icon
6011
Capital Southwest
CSWC
$1.59B
$738K ﹤0.01%
35,220
+21,161
+151% +$460K
SSD icon
6012
PUT
Simpson Manufacturing
SSD
$7.94B
$738K ﹤0.01%
11,100
+2,100
+23% +$134K
TV icon
6013
Televisa
TV
$1.53B
$738K ﹤0.01%
87,403
-29,285
-25% -$285K
PETQ
6014
PUT
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$738K ﹤0.01%
+22,400
New +$660K
EWK icon
6015
iShares MSCI Belgium ETF
EWK
$162M
$737K ﹤0.01%
+40,198
New +$744K
GCC icon
6016
WisdomTree Enhanced Commodity Strategy Fund
GCC
$281M
$737K ﹤0.01%
41,335
+18,100
+78% +$322K
SJB icon
6017
ProShares Short High Yield
SJB
$47.6M
$737K ﹤0.01%
34,410
+24,341
+242% +$530K
TGP
6018
PUT
DELISTED
Teekay LNG Partners L.P.
TGP
$736K ﹤0.01%
52,200
-1,600
-3% -$22.8K
PSDO
6019
DELISTED
Presidio, Inc. Common Stock
PSDO
$736K ﹤0.01%
+53,852
New +$758K
IBTX
6020
CALL
DELISTED
Independent Bank Group, Inc.
IBTX
$736K ﹤0.01%
13,400
+6,200
+86% +$337K
OPTU
6021
CALL
Optimum Communications Inc
OPTU
$251M
$735K ﹤0.01%
30,200
-7,000
-19% -$166K
LDOS icon
6022
PUT
Leidos
LDOS
$18B
$735K ﹤0.01%
9,200
-4,000
-30% -$292K
IR icon
6023
Ingersoll Rand
IR
$32.3B
$734K ﹤0.01%
21,220
-787,592
-97% -$25.4M
VTHR icon
6024
Vanguard Russell 3000 ETF
VTHR
$4.88B
$734K ﹤0.01%
+5,465
New +$720K
MPWR icon
6025
CALL
Monolithic Power Systems
MPWR
$68.9B
$733K ﹤0.01%
5,400
-10,200
-65% -$1.39M

Similar funds

Ken Griffin's Q2 2019 Portfolio in Review

As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
  • Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.